RECENT TRENDS
Revising the lists for reimbursement: Italy, France, Belgium,
Regional decisions for reimbursement (Italy)
From negative list to positive list ? (UK, Germany, Spain)
Increased role for pharmacoeconomic ex ante in reaching reimbursement decision
Reimbursing up to the level of the corresponding generic (Italy, France, Germany, Spain)
Limits to patient/demand side management